Nidan Laboratories and Healthcare Limited

₹13.40As of Sun 8 Nov 2026, 12:00 UTC
NSE:NIDANHealthcare
Country India
PE (Fwd) •••
TSR 5Y CAGR (26.25%)
Div yield —
ROE 1.66%
Medical Care Facilities
Beta (5Y) 0.05
PE TTM 16.00
TSR TTM (27.96%)
Mkt cap ₹186.3M
ROIC 1.89%
SE Grade™
Value
Quality
Moat
Consensus
Reference
₹13
(2.28%)
(96.36%)
Hold 2|11|6|11|10
3Q26
4Q26
1Q27
2Q27
Earnings per share₹
0.20
0.20
0.20
0.19
3.46%
(0.90%)
(4.51%)
(6.53%)
Revenue₹M
10.37
10.69
11.26
11.90
5.57%
7.90%
11.60%
18.89%
Peers (US$1.850M)
Cap (US$)
PE
8.619M
27.07x
5.872M
98.29x
Capital
TTM
5Y
10Y
Leveragex
0.053
2.777
2.395
EBIT/Intx
0.112
0.289
0.277
Own earn%
(91.43)
(5.75)
(17.03)
Sh yield%
29.12
51.56
52.96
Owners
Insiders/Inst%
10.90
57.43
Short interest%
2.72
SBC / revenue%
1.62
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
12
Op margin range%
9–15
$1 testx
−0.1
Incr. ROIC%
8